Comparison of Platelet Indices in ST Elevation Myocardial Infarction and Non-ST Elevation Myocardial Infarction Patients At Advent Hospital Bandar Lampung

Wahyu Setianing Budi; Hidayat; Neno Fitriyani Hasbie; Devita Febriani Putri

doi:10.30872/

Authors

Wahyu Setianing Budi Universitas Malahayati Author
Hidayat Universitas Malahayati Author https://orcid.org/0009-0007-0445-1537 (unauthenticated)
Neno Fitriyani Hasbie Universitas Malahayati Author https://orcid.org/0000-0002-7245-7400 (unauthenticated)
Devita Febriani Putri Universitas Malahayati Author https://orcid.org/0000-0002-4602-736X (unauthenticated)

DOI:

https://doi.org/10.30872/

Keywords:

Warfarin, atrial fibrillation, recurrent stroke, dose switching, body mass index

Abstract

Acute Coronary Syndrome (ACS) remains a major cause of cardiovascular morbidity and mortality worldwide. Platelet activation plays a crucial role in the atherothrombotic process underlying ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI). This study aimed to analyze differences in platelet indices between STEMI and NSTEMI patients at Advent Hospital Bandar Lampung. An analytical observational study with a retrospective approach was conducted involving 104 eligible patients. Data were collected from medical records and analyzed using the chi-square, Mann–Whitney, and independent samples t-tests. The results showed that sex was significantly associated with myocardial infarction type (p=0.018), while NSTEMI patients were significantly older than STEMI patients (p=0.014). The median platelet count was significantly higher in STEMI patients than in NSTEMI patients (416,500 vs. 310,000 cells/mm³; p<0.001). Mean MPV, PDW, and PCT values were also significantly higher in STEMI patients, with p-values of 0.015, 0.001, and 0.007, respectively. In conclusion, platelet count, Mean Platelet Volume (MPV), Platelet Distribution Width (PDW), and Plateletcrit (PCT) differed significantly between STEMI and NSTEMI patients and may serve as additional hematological parameters in the evaluation of ACS patients.

Author Biographies

Wahyu Setianing Budi, Universitas Malahayati

Department of Medicine, Faculty of Medicine, Universitas Malahayati, Bandar Lampung, Indonesia
Hidayat, Universitas Malahayati

Department of Clinical Pathology, Faculty of Medicine, Universitas Malahayati, Bandar Lampung, Indonesia
Neno Fitriyani Hasbie, Universitas Malahayati

Public Health Program, Faculty of Medicine, Universitas Malahayati, Bandar Lampung, Indonesia
Devita Febriani Putri, Universitas Malahayati

Department of Parasitology, Faculty of Medicine, Universitas Malahayati, Bandar Lampung, Indonesia

References

[1] A. D. Juzar et al., Pedoman Tata Laksana Sindrom Koroner Akut Edisi ke-5. Jakarta: PERKI, 2024.

[2] C. Tanto, F. Liwang, S. Hanifati, and E. A. Pradipta, Kapita Selekta Kedokteran Jilid II Edisi V. Jakarta: Media Aesculapius Fakultas Kedokteran Universitas Indonesia, 2020.

[3] World Health Organization, Cardiovascular Diseases. Geneva, Switzerland: World Health Organization, 2021.

[4] Kementerian Kesehatan Republik Indonesia, Survei Kesehatan Indonesia Tahun 2023. Jakarta: Kementerian Kesehatan Republik Indonesia, 2024.

[5] F. Polat, Z. Kaya, and A. Yanikoglu, “Platelet Distribution Width as a Marker for Severity and Extent of Coronary Artery Disease in Acute Coronary Syndrome,” International Journal of Cardiovascular Sciences, vol. 38, pp. 1–7, 2025.

[6] B. He and Q. Sun, “Prognostic Value of Mean Platelet Volume and Platelet Distribution Width for the Outcomes of Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention,” American Journal of Translational Research, vol. 17, no. 3, pp. 2083–2093, 2025.

[7] A. A. Mir et al., “Analysis of Platelet Volume Indices and Their Utility in Acute Coronary Syndrome,” Heart Views, vol. 25, no. 4, pp. 229–235, 2024.

[8] G. Krishnan, M. M. Prabhu, and W. Stanley, “Platelet Indices as Diagnostic and Prognostic Markers in Acute Coronary Syndrome,” F1000Research, vol. 13, no. 927, pp. 1–10, 2024.

[9] H. Mushtaq, M. Shabbir, S. Mukarram, and M. Altaf, “Association of Admission Platelet Crit with In-Hospital Outcomes in Non ST-Elevation Myocardial Infarction (NSTEMI),” Pakistan Armed Forces Medical Journal, vol. 75, pp. 397–403, 2025.

[10] I. Qothi, M. R. Fuadi, and A. Subagjo, “Profile of Major Risk Factors in Acute Coronary Syndrome (ACS) at Pusat Pelayanan Jantung Terpadu (PPJT) Dr. Soetomo Public Hospital Surabaya Between the Period of January–December 2019,” Cardiovascular & Cardiometabolic Journal, vol. 2, no. 2, pp. 59–72, 2021.

[11] N. S. Alaydrus, S. Q. Rizki, M. Fauzan, and R. R. Rasyid, “Karakteristik Klinis Pasien Sindrom Koroner Akut dan Kronik: Sebuah Studi Observasional di Rumah Sakit Rujukan Aceh,” Jurnal Kesehatan Malahayati, vol. 12, no. 8, pp. 1802–1809, 2025.

[12] V. Regitz-Zagrosek and S. Kararigas, “Mechanisms of Sex Differences in Cardiovascular Disease,” Physiological Reviews, vol. 97, no. 1, pp. 1–37, 2017.

[13] P. Libby, “The Changing Landscape of Atherosclerosis,” Nature, vol. 592, no. 7855, pp. 524–533, 2021.

[14] T. Melyani, L. N. Ambunan, and E. P. Baringbing, “Hubungan Usia dengan Kejadian Penyakit Jantung Koroner pada Pasien Rawat Jalan di RSUD dr. Doris Sylvanus Provinsi Kalimantan Tengah,” Jurnal Surya Medika, vol. 9, no. 1, pp. 119–125, 2023.

[15] A. A. Damluji et al., “Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association,” Circulation, vol. 147, no. 1, pp. 1–30, 2023.

[16] M. Zaheen et al., “Myocardial Infarction in the Young: Aetiology, Emerging Risk Factors, and the Role of Novel Biomarkers,” Journal of Cardiovascular Development and Disease, vol. 12, no. 4, Art. no. 148, 2025.

[17] T. Noviyanti, Suryanto, and W. S. Hadi, “Hubungan Trombosit dan Troponin I pada Penyakit Jantung Koroner di RS PKU Muhammadiyah Gamping,” Jurnal Kesehatan Tambusai, vol. 6, no. 3, pp. 9817–9824, 2025.

[18] N. K. Mohanty, C. Satpathy, S. Routray, and B. Dash, “Correlation of Platelet Indices with the Spectrum of Acute Coronary Syndrome and Extent of Coronary Artery Disease,” Panacea Journal of Medical Sciences, vol. 12, no. 1, pp. 164–171, 2022.

[19] A. Ali, R. Gibbs, J. Knight, and D. Tsitsikas, “Sex-divided Reference Intervals for Mean Platelet Volume, Platelet Large Cell Ratio and Plateletcrit Using the Sysmex XN-10 Automated Haematology Analyzer in a UK Population,” Hematology, Transfusion and Cell Therapy, vol. 41, no. 2, pp. 153–157, 2019.

[20] D. Astuti and E. Maharani, “Nilai Indeks Trombosit Sebagai Kontrol Kualitas Komponen Konsentrat Trombosit,” Meditory, vol. 8, no. 2, pp. 85–94, 2020.

[21] F. Bashir, T. A. Mali, A. Ashraf, T. A. Eli, and F. Amin, “Platelet Indices in Acute Myocardial Infarction: An Observational Study,” Annals of Medicine and Medical Sciences, vol. 4, no. 10, pp. 937–944, 2025.

[22] R. C. M. Botros and R. Quayyum, “Association of Platelet Distribution Width With All-cause and Cause-specific Mortality in US Adults,” International Journal of Cardiology, vol. 407, Art. no. 132100, 2024.

[23] N. Esmiralda, N. Rusdani, and I. D. Nugroho, “Hubungan Kadar Kolesterol terhadap Kejadian Sindrom Koroner Akut pada Pasien Poli Jantung dan Pembuluh Darah di RSBP Kota Batam,” Jurnal Zona Kedokteran Universitas Batam, vol. 13, no. 2, pp. 424–430, 2023.

[24] H. E. Hassan, N. A. Kamal, E. T. M. Kafafy, T. A. H. N. Mahran, and E. H. Mahran, “Platelet Indices and Blood Cell Ratios in Acute Coronary Syndrome and Their Predictive Values,” Journal of Current Medical Research and Practice, vol. 5, no. 1, pp. 57–62, 2020.

[25] Q. Hu et al., “Daily Exercise Improves the Long-term Prognosis of Patients With Acute Coronary Syndrome,” Frontiers in Public Health, vol. 11, pp. 1–13, 2023.

[26] R. C. M. Intravia, C. Tognola, A. Maloberti, F. Brucato, E. Campione, and C. Gianmatteo, “The Role of Inflammation in Acute Coronary Syndrome: A Systematic Review on Biochemical Inflammatory Assessment and Anti-inflammatory Therapies,” International Journal of Cardiology: Heart & Vasculature, vol. 30, pp. 1–24, 2020.

[27] S. Pabbi et al., “Reference Interval of Platelet Counts and Other Platelet Indices in Apparently Healthy Blood Donors in North India According to Clinical and Laboratory Standards Institute,” Asian Journal of Transfusion Science, vol. 16, no. 2, pp. 245–250, 2022.

[28] M. Poudineh et al., “Platelet Distribution Width and White Blood Cell are Associated With Cardiovascular Diseases: Data Mining Approaches,” Blood Pressure, vol. 32, no. 1, Art. no. 2246190, 2023.

[29] U. Sukorini, A. Azis, R. Ratnaningsih, and D. Satria, “Normal Value of Thrombocyte Indices in Indonesian Adults: Focus on Gender and Ages,” The Indonesian Biomedical Journal, vol. 16, no. 4, pp. 292–396, 2024.

[30] S. M. Ahmed et al., “Correlation of Mean Platelet Volume with ST Segment Resolution after Thrombolytic Therapy in Patients with ST Elevation Myocardial Infarction,” Mymensingh Medical Journal: MMJ, vol. 29, no. 3, pp. 553–559, Jul. 2020.

[31] S. P. Tasneem, “Abstract 13525: Plateletcrit: A Novel Risk Predictor of Acute Myocardial Infarction,” Circulation, vol. 148, no. Suppl. 1, Nov. 2023, doi: 10.1161/circ.148.suppl_1.13525.

[32] G. I. Mohamed and B. N. Nashy, “Mean Platelet Volume as a Biomarker for Detection of Reperfusion Abnormalities in STEMI Patients Treated with Primary PC,” The Medical Journal of Cairo University, vol. 90, no. 12, pp. 2143–2150, Dec. 2022, doi: 10.21608/mjcu.2022.287345.